GlassScriptPhysician profile
Lawrence A Bass
NPI 1467481945
$983.01
in general payments reported to CMS, 2019-2025
16 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.16 · 2021: $31.49 · 2022: $610 · 2023: $100 · 2024: $77.43 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $246.05 | 2022-2025 | Jada System, Nexplanon |
| Hologic Sales and Service, LLC | $153.95 | 2022-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Medical Device Business Services, INC. | $125.00 | 2022 | |
| Gynesonics, INC. | $96.69 | 2022 | |
| Shield Therapeutics INC | $72.74 | 2023-2025 | Accrufer |
| Evofem Biosciences, INC. | $56.86 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $51.61 | 2023-2025 | |
| Astellas Pharma US INC | $29.50 | 2024 | Veozah |
| Avion Pharmaceuticals | $28.75 | 2019-2023 | Balcoltra |
| Abbvie INC. | $25.59 | 2023 | Orilissa |
| Coopersurgical, INC. | $21.00 | 2023 | Paragard T 380a |
| Exeltis, USA INC. | $17.70 | 2022 | |
| Viiv Healthcare Company | $15.57 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.07 | 2022 | |
| Scynexis, INC. | $14.10 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Bass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.